Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» diabetes
diabetes
MannKind's Afrezza Sales Remain Below 300 Scripts - Can The Company Increase Sales Soon?
Seeking Alpha
Tue, 11/22/16 - 11:23 am
MannKind
Afrezza
diabetes
inhaled insulin
Sanofi Took $100M Hit on MannKind Deal
Investopedia
Sat, 11/12/16 - 04:35 pm
Sanofi
MannKind
Afrezza
diabetes
inhaled insulin
MannKind, Sanofi Reach Agreement on AFREZZA; Sanofi to Purchase $10.2M Worth of Insulin from MannKind
Yahoo/Benzinga
Thu, 11/10/16 - 12:28 pm
MannKind
Sanofi
Afrezza
inhaled insulin
diabetes
World Leader in Diabetes Medication Hits 2-Year Low
Yahoo/GuruFocus
Mon, 11/7/16 - 09:30 pm
diabetes
Novo Nordisk
MannKind: Afrezza Sales Fizzle Going Into Quarterly Call
Seeking Alpha
Sat, 11/5/16 - 02:08 pm
MannKind
Afrezza
diabetes
inhaled insulin
earnings
Bernie Sanders calls for federal investigation of insulin makers for price collusion
Stat/Pharmalot
Fri, 11/4/16 - 10:21 am
Bernie Sanders
drug pricing
insulin
diabetes
price collusion
Eli Lilly
Novo Nordisk
Sanofi
US Still the Largest Market for Novo Nordisk
Market Realist
Wed, 11/2/16 - 09:50 am
Novo Nordisk
diabetes
United States
Eli Lilly shares fall on Bernie Sanders tweet
CNBC
Tue, 11/1/16 - 04:56 pm
Eli Lilly
Bernie Sanders
drug pricing
diabetes
Humalog
insulin
Fate of Lilly's Jardiance franchise rests on FDA's delayed heart-benefits indication
Fierce Pharma
Tue, 11/1/16 - 10:13 am
Eli Lilly
Jardiance
FDA
diabetes
Boehringer Ingelheim
Sanofi 'reshapes' as diabetes franchise continues to flounder
BioPharma Dive
Tue, 11/1/16 - 10:12 am
Sanofi
diabetes
earnings
Trial suggests Flexion’s knee injection may be safer for diabetes patients
Bizjournals.com
Tue, 11/1/16 - 10:09 am
Flexion
diabetes
Zilretta
osteoarthritis of the knee
New Novo Nordisk Strategy Drops Oral Insulin, Expands Oral GLP-1
Seeking Alpha
Sun, 10/30/16 - 11:14 am
Novo Nordisk
diabetes
oral insulin
insulin
GLP-1 agonist
R&D
Novo equipped to weather the storm in the U.S. diabetes market, CEO says
Fierce Pharma
Sat, 10/29/16 - 01:22 pm
Novo Nordisk
diabetes
Lars Sorenson
drug pricing
Could This Look-A-Like Drug Be Merck's Next Big Seller?
Motley Fool
Sat, 10/29/16 - 01:21 pm
MK-1293
Merck
diabetes
insulin
Lantus
biosimilars
Lexicon's Phase 2 Diabetes Study Looks Good
Investopedia
Wed, 10/26/16 - 08:49 am
Lexicon Pharmaceuticals
sotagliflozin
type 1 diabetes
diabetes
Eli Lilly is expanding its global reach: CEO
CNBC
Tue, 10/18/16 - 09:31 am
Eli Lilly
Pharma CEOs
John Lechleiter
diabetes
tuberculosis
Merck inks pay-for-performance deal to boost diabetes drugs
BioPharma Dive
Thu, 10/13/16 - 10:33 am
Merck
pay-for-performance
diabetes
Janumet
Januvia
Aetna
New diabetes tech is coming. But will it make much difference?
Stat
Tue, 10/11/16 - 09:57 am
diabetes
Medtech
devices
wearables
J&J warns diabetic patients: Insulin pump vulnerable to hacking
Yahoo/Reuters
Wed, 10/5/16 - 09:32 am
JNJ
diabetes
insulin pumps
devices
device security
Animas OneTouch
Novo Nordisk eyes drug development program
Mass Device
Tue, 10/4/16 - 10:15 am
Novo Nordisk
diabetes
drug development
Pages
« first
‹ previous
…
37
38
39
40
41
42
43
44
45
…
next ›
last »